Is CLSN or EQR a better dividend investment in 2026?

CLSN currently yields 102.74% with a 5% 5-year dividend growth rate. EQR yields 4.73% with 5% growth. The better choice depends on your goal: CLSN offers higher current income.

What is the dividend yield difference between CLSN and EQR?

CLSN has a forward dividend yield of 102.74% ($2.00/share annually). EQR yields 4.73% ($2.77/share annually). The yield gap is 98.01 percentage points.

Home › Compare › CLSN vs EQR

CLSN vs EQR: Dividend Comparison 2026

CLSN yields 102.74% · EQR yields 4.73%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CLSN wins by $4.31M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CLSN

● Live price

102.74%

Share price

$1.95

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.36M

Annual income

$1,494,304.71

Full CLSN calculator →

EQR

● Live price

4.73%

Share price

$58.58

Annual div

$2.77

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$40.5K

Annual income

$3,819.61

Full EQR calculator →

Portfolio growth — CLSN vs EQR

📍 CLSN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CLSN	EQR
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CLSN + EQR cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CLSN pays

EQR pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLSN

Annual income on $10K today (after 15% tax)

$8,733.18/yr

After 10yr DRIP, annual income (after tax)

$1,270,159.00/yr

EQR

Annual income on $10K today (after 15% tax)

$401.93/yr

After 10yr DRIP, annual income (after tax)

$3,246.67/yr

At 15% tax rate, CLSN beats the other by $1,266,912.34/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLSN + EQR for your $10,000?

CLSN: 50%EQR: 50%

100% EQR50/50100% CLSN

Portfolio after 10yr

$2.20M

Annual income

$749,062.15/yr

Blended yield

34.08%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

CLSN

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Altman Z

-7819.1

Piotroski

3/9

EQR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$70.35

+20.1% upside vs current

Range: $63.00 — $78.50

Altman Z

1.8

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLSN buys

EQR buys

No recent congressional trades found for CLSN or EQR in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCLSNEQR

Forward yield	102.74% ✓	4.73%
Annual dividend / share	$2.00	$2.77 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$4.36M	$40.5K ✓
Annual income after 10y	$1,494,304.71 ✓	$3,819.61
Total dividends collected	$3.90M	$16.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	REIT
Analyst consensus	Buy	Hold

Year-by-year: CLSN vs EQR ($10,000, DRIP)

Year	CLSN Portfolio	CLSN Income/yr	EQR Portfolio	EQR Income/yr	Gap
1← crossover	$20,974	$10,274.32	$11,248	$547.57	+$9.7K → CLSN
2	$42,582	$20,139.91	$12,701	$666.53	+$29.9K → CLSN
3	$83,777	$38,213.45	$14,405	$814.59	+$69.4K → CLSN
4	$159,904	$70,262.72	$16,413	$999.84	+$143.5K → CLSN
5	$296,433	$125,336.27	$18,795	$1,232.92	+$277.6K → CLSN
6	$534,334	$217,150.75	$21,639	$1,527.95	+$512.7K → CLSN
7	$937,555	$365,816.85	$25,057	$1,903.80	+$912.5K → CLSN
8	$1,603,062	$599,878.65	$29,197	$2,385.87	+$1.57M → CLSN
9	$2,673,868	$958,591.11	$34,250	$3,008.70	+$2.64M → CLSN
10	$4,355,343	$1,494,304.71	$40,467	$3,819.61	+$4.31M → CLSN

CLSN vs EQR: Complete Analysis 2026

CLSN — Stock

Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.

Full CLSN Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →

📬

Get this CLSN vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLSN vs SCHD CLSN vs JEPI CLSN vs O CLSN vs KO CLSN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.